MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    In-vivo free-water imaging and functional connectivity in a knock-in mouse model of DYT1 dystonia

    J.C. DeSimone, M. Febo, P. Shukla, E. Ofori, L.M. Colon-Perez, Y. Li, D.E. Vaillancourt (Gainesville, FL, USA)

    Objective: To examine in-vivo functional connectivity and free-water diffusion imaging in dystonic mutant Tor1a knock-in (DYT1) and wild-type (WT) control mice. We test the hypothesis…
  • 2016 International Congress

    Pallidal deep brain stimulation improves dystonia in Woodhouse-Sakati syndrome

    J.Y. Chen, J.L. Ostrem, B. Lee, P. Starr, A. Viehoever (San Francisco, CA, USA)

    Objective: To describe a patient with a rare genetic disorder, Woodhouse-Sakati Syndrome, treated with deep brain stimulation (DBS) for dystonia. Background: Woodhouse-Sakati Syndrome (WSS) is…
  • 2016 International Congress

    Sensorimotor gray matter changes in professional brass players with and without Embouchure dystonia

    T.A. Mantel, C. Dresel, E. Altenmüller, A. Jochim, G. Gora-Stahlberg, C. Zimmer, B. Haslinger (Munich, Germany)

    Objective: To investigate patterns of gray matter alterations in professional brass musicians with embouchure dystonia (ED) in relation to healthy professional brass musicians and to…
  • 2016 International Congress

    Functional characterization of the upstream start codon in the GCH1 gene

    L.C. Jones, E. Davila, L.K. Goode, P.G. Bhide, I. Armata (Tallahassee, FL, USA)

    Objective: To examine (1) the -22C > T point mutation which introduces a premature start codon upstream of the normal open reading frame (ORF) of…
  • 2016 International Congress

    Botulinum toxin type A therapy for blepharospasm – Update of a Cochrane systematic review and meta-analysis

    R.E. Marques, G.S. Duarte, F.B. Rodrigues, M. Castelão, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)

    Objective: To compare the effects of botulinum toxin type A (BtA) versus placebo in blepharospasm. Background: This is an update of a Cochrane systematic review.…
  • 2016 International Congress

    Alternating hemiplegia of childhood: Movement disorders and epilepsy due to mutuations in ATP1A3

    A.P. Kleinert-Altamirano, M.O. Fiesco-Roa, K. Brockmann, E. Liebermann-Hernández, C. Marques-Lourenco (Tuxtla Gutiérrez, Mexico)

    Objective: To present 2 cases of children with genetic confirmative test of alternating hemiplejia of childhood. Background: Alternating hemiplegia of childhood (AHC) is a dominant…
  • 2016 International Congress

    Physical therapy, a third wheel in the management of Parkinson’s disease

    M.V. Alvarez, M. Rodriguez (San Antonio, TX, USA)

    Objective: To reinforce the importance of physical therapy in the management of Parkinson's disease. Background: Unsteadiness, falling, and tendency to fall are frequent symptoms of…
  • 2016 International Congress

    Finding an optimal lead trajectory for a better stimulated volume in movement disorder therapy

    J. Perez, L. Cif, V. Gonzalez, E. Sanrey, F. Cyprien, P. Coubes (Montpellier, France)

    Objective: Defining the best lead trajectory (Arc; Ring) with a computational 3D stereotactic model of the Globus Pallidus internus (GPi) and investigating the influence of…
  • 2016 International Congress

    EEG Spectral power changes prior to non-epileptic seizures: A pilot study

    A.M. Meppelink, I. Parees, M. Beudel, S. Little, M. Edwards (Groningen, Netherlands)

    Objective: To assess possible EEG spectral power changes prior to psychogenic non-epileptic seizures (PNES) and identify whether a “positive marker” of PNES may exist. Background:…
  • 2016 International Congress

    A rapid chemical-genetic screen utilising impaired movement phenotypes in caenorhabditis elegans

    K. Schmeisser, Y.F. Ghassemi, C. Maios, A. Parker (Montreal, QC, Canada)

    Objective: Development of a fast and unbiased screening method to identify C. elegans mutants with movement disabilities and drugs to improve impaired locomotion. Background: Identifying…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley